C.H. Robinson to Acquire RXO

RXO, Inc. has agreed to be acquired by C.H. Robinson in a stock-and-cash deal. The combined entity will offer expanded freight services. RXO will operate independently until the transaction closes. The deal is subject to regulatory approvals and other conditions.

C.H. Robinson Worldwide's stock rose 5.2% to $142.19 after Truist, Evercore, and JP Morgan maintained Buy/Outperform ratings while lowering price targets. The average target is now $205. The company's market cap is $16.6B.

C.H. Robinson (CHRW) agreed to acquire RXO in a $5.8B cash-and-stock deal, expected to close by mid-2027. The acquisition aims to expand CHRW's scale, technology, and service offerings, particularly in last-mile and expedite services. RXO's strengths in healthcare and automotive sectors, along with its technology, are key drivers. Integration will focus on combining data, technology, and lean AI strategies.

C.H. Robinson Worldwide agreed to acquire RXO (RXO) in a $5.8b cash and stock deal. RXO's stock surged 38.61% in 7 days and 37.27% in 30 days, with a 120.87% year-to-date return. The stock closed at $28.36, above a fair value estimate of $26.23, but faces risks from soft freight conditions and legal liabilities.

C.H. Robinson (CHRW) plans to acquire RXO in a $5.8B deal, creating a company with over $25B enterprise value. Analysts see strategic benefits, including expanded brokerage scale and cost synergies, but warn of integration risks and legal uncertainties. CHRW's stock initially dropped post-announcement, with analysts citing long-term potential.

JPMorgan upgraded RXO Inc. to 'Neutral' from 'Underweight' and set a price target of $30. The stock has risen 37.81% year-to-date and 125.79% over the past year, with a current price of $28.54. The upgrade is based on valuation, earnings revisions, and visibility metrics.